Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome

Manuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, Matthias Weissinger, Helmut Dittmann, Christian la Fougère and Francesco Fiz
Journal of Nuclear Medicine September 2023, 64 (9) 1431-1438; DOI: https://doi.org/10.2967/jnumed.122.264770
Manuela Straub
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Kupferschläger
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina Maria Serna Higuita
2Institute of Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Weissinger
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
3Department of Radiology, University Hospital, Tübingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helmut Dittmann
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian la Fougère
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
4Cluster of Excellence 2180 “Image-Guided and Functionally Instructed Tumor Therapies,” Eberhard Karls University, Tübingen, Germany;
5German Cancer Consortium, German Cancer Research Center Partner Site Tübingen, Tübingen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Fiz
1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
6Nuclear Medicine Unit, Department of Diagnostic Imaging, Ente Ospedaliero “Ospedali Galliera,” Genoa, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 9 1431-1438
DOI 
https://doi.org/10.2967/jnumed.122.264770
PubMed 
37414446

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 7, 2022
  • Revision received April 20, 2023
  • Published online September 1, 2023.

Article Versions

  • previous version (July 6, 2023 - 07:58).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Manuela Straub1,
  2. Jürgen Kupferschläger1,
  3. Lina Maria Serna Higuita2,
  4. Matthias Weissinger1,3,
  5. Helmut Dittmann1,
  6. Christian la Fougère1,4,5 and
  7. Francesco Fiz1,6
  1. 1Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Germany;
  2. 2Institute of Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany;
  3. 3Department of Radiology, University Hospital, Tübingen, Germany;
  4. 4Cluster of Excellence 2180 “Image-Guided and Functionally Instructed Tumor Therapies,” Eberhard Karls University, Tübingen, Germany;
  5. 5German Cancer Consortium, German Cancer Research Center Partner Site Tübingen, Tübingen, Germany; and
  6. 6Nuclear Medicine Unit, Department of Diagnostic Imaging, Ente Ospedaliero “Ospedali Galliera,” Genoa, Italy
  1. For correspondence or reprints, contact Christian la Fougère (christian.lafougere{at}med.uni-tuebingen.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
    Silke Gillessen, Fabio Turco, Ian D. Davis, Jason A. Efstathiou, Karim Fizazi, Nicholas D. James, Neal Shore, Eric Small, Matthew Smith, Christopher J. Sweeney, Bertrand Tombal, Thomas Zilli, Neeraj Agarwal, Emmanuel S. Antonarakis, Ana Aparicio, Andrew J. Armstrong, Diogo Assed Bastos, Gerhardt Attard, Karol Axcrona, Mouna Ayadi, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Maria T. Bourlon, Alberto Briganti, Muhammad Bulbul, Consuelo Buttigliero, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N. Chi, Caroline S. Clarke, Noel Clarke, Johann S. de Bono, Maria De Santis, Ignacio Duran, Eleni Efstathiou, Onyeanunam N. Ekeke, Tamer I.H. El Nahas, Louise Emmett, Stefano Fanti, Omolara A. Fatiregun, Felix Y. Feng, Peter C.C. Fong, Valerie Fonteyne, Nicola Fossati, Daniel J. George, Martin E. Gleave, Gwenaelle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Michael S. Hofman, Thomas A. Hope, Lisa G. Horvath, Maha H.A. Hussain, Barbara Alicja Jereczek-Fossa, Robert J. Jones, Anthony M. Joshua, Ravindren Kanesvaran, Daniel Keizman, Raja B. Khauli, Gero Kramer, Stacy Loeb, Brandon A. Mahal, Fernando C. Maluf, Joaquin Mateo, David Matheson, Mika P. Matikainen, Ray McDermott, Rana R. McKay, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind Mrabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Shingai B.A. Mutambirwa, Paul L. Nguyen, William K. Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny M Rabah, Dana Rathkopf, Robert E. Reiter, Raphaele Renard-Penna, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Shahneen Sandhu, Oliver A. Sartor, Edward Schaeffer, Howard I. Scher, Nima Sharifi, Iwona A. Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Hiroyoshi Suzuki, Mary-Ellen Taplin, Camilla Thellenberg-Karlsson, Derya Tilki, Levent N. Türkeri, Hiroji Uemura, Yüksel Ürün, Claire L. Vale, Neha Vapiwala, Jochen Walz, Kosj Yamoah, Dingwei Ye, Evan Y. Yu, Almudena Zapatero, Aurelius Omlin
    European Urology 2025 87 2
  • 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice
    Kim N. Chi, Steven M. Yip, Glenn Bauman, Stephan Probst, Urban Emmenegger, Christian K. Kollmannsberger, Patrick Martineau, Tamim Niazi, Frédéric Pouliot, Ricardo Rendon, Sebastien J. Hotte, David T. Laidley, Fred Saad
    Current Oncology 2024 31 3
  • Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis
    Ludmila Santiago Almeida, Irene García Megías, Elba Cristina Sá Camargo Etchebehere, Adriana K. Calapaquí Terán, Ken Herrmann, Francesco Giammarile, Giorgio Treglia, Roberto C. Delgado Bolton
    European Journal of Nuclear Medicine and Molecular Imaging 2025 52 3
  • Development of Novel Radiotheranostic Ligand with Positively Charged Unit Targeting Prostate-Specific Membrane Antigen
    Takuma Hasegawa, Kazuma Nakashima, Yuta Tarumizu, Masatoshi Tada, Yoshifumi Maya, Hiroyuki Watanabe, Masahiro Ono
    Journal of Medicinal Chemistry 2025 68 10
  • Treatment response assessment in mCRPC: is PSMA-PET/CT going to take the lead?
    Martina Di Franco, Riccardo Mei, Camilo Garcia, Stefano Fanti
    Therapeutic Advances in Medical Oncology 2024 16

Article usage

Article usage: July 2023 to April 2025

AbstractFullPdf
Jul 202313657556
Aug 20233771910
Sep 202311185570
Oct 20233956929
Nov 20239822328
Dec 2023738925
Jan 202410916147
Feb 20246428338
Mar 20243415628
Apr 20244011044
May 2024236832
Jun 20243110537
Jul 20241715144
Aug 20242311627
Sep 2024285632
Oct 2024235024
Nov 2024138548
Dec 2024165920
Jan 202510162113
Feb 20251413137
Mar 2025165819
Apr 2025137054
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (9)
Journal of Nuclear Medicine
Vol. 64, Issue 9
September 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome
Manuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, Matthias Weissinger, Helmut Dittmann, Christian la Fougère, Francesco Fiz
Journal of Nuclear Medicine Sep 2023, 64 (9) 1431-1438; DOI: 10.2967/jnumed.122.264770

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dual-Time-Point Posttherapy 177Lu-PSMA-617 SPECT/CT Describes the Uptake Kinetics of mCRPC Lesions and Prognosticates Patients’ Outcome
Manuela Straub, Jürgen Kupferschläger, Lina Maria Serna Higuita, Matthias Weissinger, Helmut Dittmann, Christian la Fougère, Francesco Fiz
Journal of Nuclear Medicine Sep 2023, 64 (9) 1431-1438; DOI: 10.2967/jnumed.122.264770
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Is Long–Axial-Field-of-View PET/CT Cost-Effective? An International Health–Economic Analysis
  • Multicycle Dosimetric Behavior and Dose–Effect Relationships in [177Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy
Show more Clinical Investigation

Similar Articles

Keywords

  • 177Lu-PSMA-617
  • RLT
  • SPECT/CT
  • mCRPC
  • dual time point
SNMMI

© 2025 SNMMI

Powered by HighWire